Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
George M. Warimwe(Kenya Medical Research Institute), Sarah C. Gilbert(Nuffield Orthopaedic Centre), Amar Lall(University of Oxford), Adrian V. S. Hill(Jenner Institute), Alejandro Brun(Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria), Gema Lorenzo(Centro de Investigación en Sanidad Animal), Alexandra J. Spencer(University of Oxford), Alison Turner(UCB Pharma (United Kingdom)), Matthew G. Cottingham(University of Oxford), Matthew D. J. Dicks(University of Oxford), Arturo Reyes‐Sandoval(Instituto Politécnico Nacional), Katharine A. Collins(Radboud University Nijmegen), Elena López-Gil(Institute of Agrifood Research and Technology), Julie Furze(University of Oxford)
Cited by 60
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|Cell|2021|1.2k
Antibody evasion by the P.1 strain of SARS-CoV-2
|Cell|2021|661